Information  X 
Enter a valid email address

Xenetic Biosciences (XEN)

  Print      Mail a friend

Thursday 28 June, 2012

Xenetic Biosciences

Result of AGM

RNS Number : 3600G
Xenetic Biosciences PLC
28 June 2012


Xenetic Biosciences plc

('Xenetic' or 'the Company')


Result of AGM


Xenetic Biosciences plc (LSE: XEN.L), a bio-pharmaceutical company specialising in the development of high-value differentiated biological and vaccines and novel cancer drugs, held  its Annual General Meeting today at the offices of Pinsent Masons LLP at 30 Crown Place, London EC2A 4ES. All resolutions were duly passed.




Xenetic Biosciences plc

+44 (0)20 3021 1500

M. Scott Maguire, Chief Executive Officer

Singer Capital Markets (NOMAD & Broker)

+44 (0)20 3205 7500

Claes Spång

Walbrook PR

+44 (0)20 7933 8780

Paul McManus (Media Enquiries)

Paul Cornelius (Investor Enquiries)


This information is provided by RNS
The company news service from the London Stock Exchange